Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.

Appendicular central osteosarcoma (OSA) is a common and highly aggressive tumour in dogs. Metastatic disease to the lungs is common and even with chemotherapy the prognosis is generally poor. However, few cases survive well beyond reported median survival times. Current methods, including histologic...

Full description

Saved in:
Bibliographic Details
Main Authors: Latasha Ludwig, Michael Edson, Heather Treleaven, Alicia M Viloria-Petit, Anthony J Mutsaers, Roger Moorehead, Robert A Foster, Ayesha Ali, R Darren Wood, Geoffrey A Wood
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0311104
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555548392128512
author Latasha Ludwig
Michael Edson
Heather Treleaven
Alicia M Viloria-Petit
Anthony J Mutsaers
Roger Moorehead
Robert A Foster
Ayesha Ali
R Darren Wood
Geoffrey A Wood
author_facet Latasha Ludwig
Michael Edson
Heather Treleaven
Alicia M Viloria-Petit
Anthony J Mutsaers
Roger Moorehead
Robert A Foster
Ayesha Ali
R Darren Wood
Geoffrey A Wood
author_sort Latasha Ludwig
collection DOAJ
description Appendicular central osteosarcoma (OSA) is a common and highly aggressive tumour in dogs. Metastatic disease to the lungs is common and even with chemotherapy the prognosis is generally poor. However, few cases survive well beyond reported median survival times. Current methods, including histologic grading schemes, have fallen short in their ability to predict clinical outcome. MicroRNAs (miRNAs) are small molecules present in all tissues and bodily fluids and are dysregulated in cancer. Previous studies have demonstrated the diagnostic and prognostic potential of miRNAs in canine OSA. We sought to investigate multiple miRNA and multiple variable models for diagnosis and prognosis of canine OSA using plasma samples across three populations of dogs from two veterinary biobanks. Fifty-six miRNAs were analyzed by real-time quantitative polymerase chain reaction. MiR-214-3p was the only miRNA with increased expression across all OSA populations compared to controls. Using a decision tree model for diagnosis, miR-214-3p was the first step in this multi-miRNA model. High expression of miR-214-3p alone was also a predictor of shorter overall survival and disease-free interval across all populations. In both multiple miRNA and multiple variable models, miR-214-3p was always the first decision point with high expression consistently predicting a worse prognosis. Additional miRNAs in combination with low expression of miR-214-3p similarly had a worse prognosis demonstrating better outcome prediction using multiple miRNAs compared to using miR-214-3p alone. Multiple variable models only need to use miRNAs to be predictive although clinical parameters such as age, sex, and tumour location were considered. MiR-214-3p is clearly an important prognostic predictor of canine OSA in plasma as supported by previous studies and across our multiple sample populations. Multiple miRNA models provided superior categorization of patients in predicting clinical outcome parameters compared to the single miRNAs.
format Article
id doaj-art-198a2fa99db84aba84e4befdc0eb9d7b
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-198a2fa99db84aba84e4befdc0eb9d7b2025-01-08T05:32:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031110410.1371/journal.pone.0311104Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.Latasha LudwigMichael EdsonHeather TreleavenAlicia M Viloria-PetitAnthony J MutsaersRoger MooreheadRobert A FosterAyesha AliR Darren WoodGeoffrey A WoodAppendicular central osteosarcoma (OSA) is a common and highly aggressive tumour in dogs. Metastatic disease to the lungs is common and even with chemotherapy the prognosis is generally poor. However, few cases survive well beyond reported median survival times. Current methods, including histologic grading schemes, have fallen short in their ability to predict clinical outcome. MicroRNAs (miRNAs) are small molecules present in all tissues and bodily fluids and are dysregulated in cancer. Previous studies have demonstrated the diagnostic and prognostic potential of miRNAs in canine OSA. We sought to investigate multiple miRNA and multiple variable models for diagnosis and prognosis of canine OSA using plasma samples across three populations of dogs from two veterinary biobanks. Fifty-six miRNAs were analyzed by real-time quantitative polymerase chain reaction. MiR-214-3p was the only miRNA with increased expression across all OSA populations compared to controls. Using a decision tree model for diagnosis, miR-214-3p was the first step in this multi-miRNA model. High expression of miR-214-3p alone was also a predictor of shorter overall survival and disease-free interval across all populations. In both multiple miRNA and multiple variable models, miR-214-3p was always the first decision point with high expression consistently predicting a worse prognosis. Additional miRNAs in combination with low expression of miR-214-3p similarly had a worse prognosis demonstrating better outcome prediction using multiple miRNAs compared to using miR-214-3p alone. Multiple variable models only need to use miRNAs to be predictive although clinical parameters such as age, sex, and tumour location were considered. MiR-214-3p is clearly an important prognostic predictor of canine OSA in plasma as supported by previous studies and across our multiple sample populations. Multiple miRNA models provided superior categorization of patients in predicting clinical outcome parameters compared to the single miRNAs.https://doi.org/10.1371/journal.pone.0311104
spellingShingle Latasha Ludwig
Michael Edson
Heather Treleaven
Alicia M Viloria-Petit
Anthony J Mutsaers
Roger Moorehead
Robert A Foster
Ayesha Ali
R Darren Wood
Geoffrey A Wood
Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
PLoS ONE
title Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
title_full Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
title_fullStr Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
title_full_unstemmed Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
title_short Plasma microRNA signatures predict prognosis in canine osteosarcoma patients.
title_sort plasma microrna signatures predict prognosis in canine osteosarcoma patients
url https://doi.org/10.1371/journal.pone.0311104
work_keys_str_mv AT latashaludwig plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT michaeledson plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT heathertreleaven plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT aliciamviloriapetit plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT anthonyjmutsaers plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT rogermoorehead plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT robertafoster plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT ayeshaali plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT rdarrenwood plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients
AT geoffreyawood plasmamicrornasignaturespredictprognosisincanineosteosarcomapatients